Acta Neuropharmacologica ›› 2015, Vol. 5 ›› Issue (1): 59-64.
WU Hua-xun,WEI Wei
Online:
2015-02-26
Published:
2015-07-06
Contact:
魏伟,男,教授,博士研究生导师;研究方向:临床药理学;Tel: +86-055165161209,E-mail:wwei@ahmu.edu.cn
About author:
吴华勋,男,博士,副教授;研究方向:临床药理学;Tel:+86-055165161206,E-mail:wuhuaxun01@163.com
Supported by:
国家自然科学基金项目 (No.81330081,81302784)
CLC Number:
WU Hua-xun,WEI Wei. The Research Progress of Adrenaline Receptor and its Signal Involved in the Regulation on Nerve Immunity in Rheumatoid Arthritis[J]. Acta Neuropharmacologica, 2015, 5(1): 59-64.
[1] Marije I Koenders, Wim B van den Berg. Novel therapeutic targets in rheumatoid arthritis [J]. Trends Pharmacol Sci, 2015, 36(4):189-195.[2] Scott I C, Scott D L. Joint counts in inflammatory arthritis[J].Clin Exp Rheumatol, 2014, 32(5 Suppl 85):S-7-12[3] Jonathan R Danoff, Garrett Moss, Barthelemy Liabaud, et al. Total knee arthroplasty considerations in rheumatoid arthritis[J]. Autoimmune Dis, 2013, 2013:185340.[4] Masaaki Iwata, Kristie T Ota, Ronald S Duman. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses[J]. Brain Behav Immun, 2013, 31:105-114.[5] Grekhov R A, Kharchenko S A, Sule?manova G P, et al. Rheumatoid arthritis: psychosomatic aspects[J].Ter Arkh, 2012, 84(12):125-130.[6] Rampton D S. The influence of stress on the development and severity of immune -mediated diseases[J]. J Rheumatol Suppl, 2011, 88:43-47. [7] Joshua D Rosenblat, Danielle S Cha, Rodrigo B Mansur, et al. Inflamed moods: A review of the interactions between inflammation and mood disorders[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2014, 53C: 23-34. [8] Kvetnansky R, Lu X, Ziegler M G. Stress-triggered changes in peripheral catecholaminergic systems[J]. Adv Pharmacol, 2013, 68:359-397. [9] Meier T, Noll-Hussong M. The role of stress axes in cancer incidence and proliferation[J]. Psychother Psychosom Med Psychol, 2014, 64(9-10):341-344.[10] Frieda A Koopman, Susanne P Stoof, Rainer H Straub, et al. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis[J]. Mol Med, 2011, 17(9-10):937-948.[11] Susanna Cotecchia. The α1-adrenergic receptors: diversity of signaling networks and regulation[J]. J Recept Signal Transduct Res, 2010, 30(6):410-419. [12] Christopher Cottingham, Wang Qin. α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy[J]. Neurosci Biobehav Rev, 2012, 36(10):2214-2225.[13] John W Calvert, David J Lefer. Role of β-adrenergic receptors and nitric oxide signaling in exercise-mediated cardioprotection[J]. Physiology (Bethesda), 2013, 28(4):216-224.[14] Zhu W, Woo A Y, Zhang Y, et al. β-adrenergic receptor subtype signaling in the heart: from bench to the bedside[J]. Curr Top Membr, 2011, 67:191-204.[15] Virginia M Sanders. The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet? [J]. Brain Behav Immun, 2012, 26(2):195-200.[16] 赵璐, 许建华.肾上腺素能受体信号通路与结直肠癌关系的研究进展[J]. 世界华人消化杂志, 2014, 22(34):5285-5290.[17] Babol K, B?asiak J. Beta3-adrenergic receptor[J]. Postepy Biochem, 2005, 51(1): 80-87.[18] 韩启德.肾上腺素受体研究进展[J].生理科学进展, 1995, 26(2): 103-109.[19] Robert N Spengler, Stephen W Chensue, Giacherio D A, et al. Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro[J]. J Immunol, 1994, 152(6):3024-3031.[20] Alfred Opolka, Rainer H Straub, Anja Pasoldt, et al. Substance P and norepinephrine modulate murine chondrocyte proliferation and apoptosis[J].Arthritis Rheum, 2012, 64(3): 729-739.[21] Rainer H Straub, Firdaus S Dhabhar, Johannes W J Bijlsma, et al. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis[J]. Arthritis Rheum, 2005, 52(1):16-26.[22] Lechin F, van der Dijs B, Lechin A, et al. Plasma neurotransmitters and cortisol in chronic illness: role of stress[J]. J Med, 1994, 25(3-4):181-192.[23] Dwight M Nance, Virginia M Sanders. Autonomic innervation and regulation of the immune system [J]. Brain Behav Immun, 2007, 21(6):736-745. [24] Denise L Bellinger, Brooke A Millar, Sam Perez, et al. Sympathetic modulation of immunity: relevance to disease[J]. Cell Immunol, 2008, 252 (1-2):27-56. [25] Wang Shu-peng, Li Gang. The progression of β-adrenergic modulation in sepsis[J]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2011, 23(8):505-508. [26] Caroline Padro, Virginia M Sanders. Neuroendocrine regulation of inflammation[J]. Semin Immunol, 2014, 26(5):357-368.[27] Maria Stella Lombardi, Kavelaars A, Schedlowski M, et al. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis[J]. FASEB J, 1999, 13(6):715-725.[28] Wahle M, Neumann R P, Moritz F, et al. Beta2 -adrenergic receptors mediate the differential effects of catecholamines on cytokine production of PBMC[J]. J Interferon Cytokine Res, 2005, 25(7):384-394.[29] Cheri L Lubahn, Jill A Schaller, Denise L Bellinger, et al. The importance of timing of adrenergic drug delivery in relation to the induction and onset of adjuvant -induced arthritis[J]. Brain Behav Immun, 2004, 18(6):563-571.[30] Wu Hong, Wei Wei, Song Li-hua, et al. Paeoniflorin induced immune tolerance of mesenteric lymph node lymphocytes via enhancing beta 2-adrenergic receptor desensitization in rats with adjuvant arthritis[J].Int Immunopharmacol, 2007, 7(5):662-673[31] Laurel A Grisanti, Andrew P Woster, Julie Dahlman, et al. α1-adrenergic receptors positively regulate Toll-like receptor cytokine production from human monocytes and macrophages[J]. J Pharmacol Exp Ther, 2011, 338(2): 648-657.[32] Rouppe van der Voort C, Kavelaars A, van de Pol M, et al. Neuroendocrine mediators up-regulate alpha1b- and alpha1d-adrenergic receptor subtypes in human monocytes[J]. J Neuroimmunol, 1999, 95(1-2):165-173.[33] Rainer H Straub, Peter Härle. Sympathetic neurotransmitters in joint inflammation[J]. Rheum Dis Clin North Am, 2005, 31(1):43-59, [34] Katsuyuki Mishima, Hitomi Otani, Takatoshi Tanabe, et al. Inagaki C. Molecular mechanisms for alpha2-adrenoceptor-mediated regulation of synoviocyte populations[J]. Jpn J Pharmacol, 2001, 85(3):214-226.[35] Lorton D, Bellinger D L, Schaller J A, et al. Altered sympathetic-to-immune cell signaling via β2-adrenergic receptors in adjuvant arthritis[J]. Clin Dev Immunol, 2013, 2013:764395. [36] Coderre T J, Basbaum A I, Dallman M F, et al. Epinephrine exacerbates arthritis by an action at presynaptic β2-adrenoceptors[J]. Neuroscience, 1990, 34(2):521-523.[37] Terence J Coderre, Allan I Basbaum, Clyde Helms, et al. High-dose epinephrine acts at alpha2-adrenoceptors to suppress experimental arthritis[J]. Brain Res, 1991, 544(2): 325-328.[38] Levine J D, Coderre T J, Helms C, et al. Beta 2-adrenergic mechanisms in experimental arthritis[J]. Proc Natl Acad Sci USA, 1988, 85(2):4553-4556.[39] Anne-Marie Malfait, Angela S Malik, Lilia Marinova-Mutafchieva, et al. The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action[J]. J Immunol, 1999, 162(10):6278-6283.[40] Harle P, Pongratz G, Straub R H. The sympathetic nervous system stimulates collagen-induced arthritis (CIA) in the induction phase and inhibits CIA in the late effector phase in DBA-1 mice[J]. Arthritis Rheum, 2003, 48:S350.[41] Yoshiya Tanaka. Pathological mechanisms in rheumatoid arthritis[J].Nihon Rinsho, 2013, 71(7):1147-1152.[42] Jose U Scher. B-cell therapies for rheumatoid arthritis[J]. Bull NYU Hosp Jt Dis, 2012, 70(3):200-203. [43] Kohm A P, Sanders V M. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo[J]. Pharmacol Rev, 2001, 53(4):487-525. [44] Michelle A Swanson, William T Lee, Virginia M Sanders. IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine[J].J Immunol, 2001, 166(1):232-240.[45] Wahle M, Stachetzki U, Krause A, et al. Regulation of beta2-adrenergic receptors on CD4 and CD8 positive lymphocytes by cytokines in vitro[J]. Cytokine, 2001,16(6):205-209.[46] Matthew J Loza, Susan Foster, Stephen Peters, et al. Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells[J]. Blood, 2006, 107(5):2052-2060.[47] Takako Kizaki, Tetsuya Izawa, Takuya Sakurai, et al. Beta2-adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappa Bactivation through beta-arrestin 2[J]. Immunology, 2008, 124(3): 348-356. [48] Matteo Martino, Giulio Rocchi, Andrea Escelsior, et al. Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance[J]. Curr Neuropharmacol, 2012, 10(2):97-123.[49] Hou N, Zhang X, Zhao L, et al. A novel chronic stress -induced shift in the Th1 to Th2 response promotes colon cancer growth[J]. Biochem Biophys Res Commun, 2013, 439(4):471-476.[50] Marcia G Guereschi, Leandro P Araujo, Juliana T Maricato, et al. Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA -dependent manner[J]. Eur J Immunol, 2013, 43(4):1001-1012.[51] Xu B Y, Arlehag L, Rantapää-Dahlquist S B, et al. Beta2 Adrenoceptor gene single nucleotide polymorphisms are associated with rheumatoid arthritis in northern Sweden[J]. Ann Rheum Dis, 2005, 64(5):773-776.[52] Lukas Bossaller, Achim Rothe. Monoclonal antibody treatments for rheumatoid arthritis[J]. Expert Opin Biol Ther, 2013, 13(9):1257-1272. [53] Zhang Ji-Hong, Hu Chong-wei, Zhu Yan-zhu, et al. Effects of norepinephrine on immune functions of cultured splenic lymphocytes exposed to aluminum trichloride[J]. Biol Trace Elem Res, 2013, 154(2):275-280. [54] Yu Xi-chun, Stavros Stavrakis, Michael A Hill, et al. Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension[J]. J Am Soc Hypertens, 2012, 6(1):40-47. [55] Kin N W, Sanders V M. It takes nerve to tell T and B cells what to do[J].J Leukoc Biol, 2006, 79(6):1093-1104. [56] Botta F, Maestroni G J. Adrenergic modulation of dendritic cell cancer vaccine in a mouse model: role of dendritic cell maturation[J]. J Immunother, 2008, 31(3):263-270.[57] Ji Hye Yang, Eun Ok Lee, Sang Eun Kim, et al. Norepinephrine differentially modulates the innate inflammatory response provoked by amyloid-β peptide via action at β-adrenoceptors and activation of cAMP/PKA pathway in human THP-1 macrophages[J]. Exp Neurol, 2012, 236(2): 199-206. |
[1] | GAO Yun-xia, ZHANG Yuan-yuan. The Role of Endoplasmic Reticulum Stress in Senile Macular Degeneration [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 21-26. |
[2] | LIN Si-mei, ZHOU Hong, YANG Bao-xue. The Relationship between Hyperuricemia and Chronic Kidney Disease [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(2): 55-64. |
[3] | LIANG Jian-hui1,2*, LIANG hui2, CHENG tao1, LIU Xiao-yan1, Simon M.Y.Lee3, TANG Ben-qin3, WANG Xiu-fen3, CHEN Feng4,Andrew J. Lawrence4. Comorbidity of Anxiety and Depression Induced by Liang’s Contextual-Stress Box in Mice [J]. Acta Neuropharmacologica, 2018, 8(4): 44-45. |
[4] | ZHONG Jia-hong, WANG Hai-tao, XU Jiang-ping. Inhibition of Phosphodiesterase 4 by FCPR16 Protects SH-SY5Y Cells against MPP+-Induced Cell Death through Activating cAMP/PKA/CREB and Epac/Akt Signaling Pathways [J]. Acta Neuropharmacologica, 2018, 8(4): 54-55. |
[5] | BAI Ru-bing,ZHANG Zhong-quan,CEN Juan. The Expression of P-Glycoprotein in Neurons and the Effect of Oxidative Stress on P-Glycoprotein [J]. Acta Neuropharmacologica, 2018, 8(3): 9-. |
[6] | XIAO Ting,MA Tian-yang,XU Xiang-qing,WANG Ke-wei. Establishment and Behavior Evaluation of Rat Chronic Unpredictable Mild Stress and Mouse Social Defeat Models [J]. Acta Neuropharmacologica, 2018, 8(1): 45-53. |
[7] | ZHANG Dan-shen,ZHANG Rui-juan. Methods and Evaluation of Animal Models of Induced Acute Respiratory Distress Syndrome [J]. Acta Neuropharmacologica, 2017, 7(6): 7-14. |
[8] | YANG Jie,LIU Fu-jia,TIAN Zi-xia,WANG Le-le,XIE Xin-mei,PANG Xiao-bin. Neuroprotective Effect of Mailuoning on MCAO Rats and Its Antioxidant Mechanism [J]. Acta Neuropharmacologica, 2017, 7(4): 1-7. |
[9] | WANG Sha-sha,ZHANG Zhao,ZHANG Mei-jin,HU Jin-feng,CHEN Nai-hong. Advances of Nrf 2/ARE Signaling Pathway in the Major Depression Disorder [J]. Acta Neuropharmacologica, 2016, 6(3): 32-37. |
[10] | WANG Huan-huan,XUE Qian,ZOU Yu-an. Research Progress of the Mechanism of Endogenous Antioxidant Stress in Cerebral Ischemic Preconditioning and Ischemia Reperfusion Injury [J]. Acta Neuropharmacologica, 2016, 6(2): 46-52. |
[11] | ZHANG Mei-jin,WANG Sha-sha,ZHANG Zhao,CHEN Nai-hong,HU Jin-feng. Role of Nuclear Transcription Factor Nrf2 in Parkinson’s Disease [J]. Acta Neuropharmacologica, 2016, 6(1): 35-40. |
[12] | LOU Yu-xia,ZHANG Zhao,WANG Zhen-zhen,JIANG Yi-na,ZHANG Yi,LI Lin,CHEN Nai-hong. Parkinson Associated DJ-1 Gene and Oxidative Stress [J]. Acta Neuropharmacologica, 2016, 6(1): 58-64. |
[13] | WANG Ying-ying, SONG Xiu-yun, WANG Qi, CHEN Nai-hong. Application of Natural Antioxidants in the Progress of Alzheimer's Disease [J]. Acta Neuropharmacologica, 2015, 5(6): 30-34. |
[14] | HU Bao-ling, GUO Chun-yan. Advances Achievements about Neuroprotective Mechanisms of Paeoniflorin [J]. Acta Neuropharmacologica, 2015, 5(6): 51-56. |
[15] | WU Bei, WANG Xin-sheng, YANG Yue-ping,TENG Jin-liang. Eff ects of Isofl urane On Neurocognitive Function and Its Possible Mechanism [J]. Acta Neuropharmacologica, 2015, 5(5): 34-39. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||